๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Phase II Trial of Oral Etoposide in Recurrent or Refractory Endometrial Adenocarcinoma: A Southwest Oncology Group Study

โœ Scribed by Elizabeth A. Poplin; P.Y. Liu; James E. Delmore; Sharon Wilczynski; Dennis F. Moore Jr.; Ronald K. Potkul; Bruce A. Fine; Edward V. Hannigan; David S. Alberts

Book ID
112247786
Publisher
Elsevier Science
Year
1999
Tongue
English
Weight
44 KB
Volume
74
Category
Article
ISSN
0090-8258

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

A phase II trial of estramustine and eto
A phase II trial of estramustine and etoposide in hormone refractory prostate cancer: A Southwest Oncology Group trial (SWOG 9407)
โœ Kenneth J. Pienta; Emily I. Fisher; Mario A. Eisenberger; Glenn M. Mills; J. Wen ๐Ÿ“‚ Article ๐Ÿ“… 2001 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 73 KB ๐Ÿ‘ 2 views

BACKGROUND. The combination of oral estramustine and oral etoposide has generated response rates of 40ยฑ50% in patients with hormone refractory prostate cancer in single institution trials. This study tested this regimen in a multi-institutional setting. METHODS. Fifty-ยฎve patients were accrued over